Full Length Research Paper
References
|
Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL (1991). Non-enzymic glycation of human extracellular superoxide dismutase. Biochem. J. 279:263-267 Pubmed |
||||
|
Aebi H (1974). Catalase. In: Methods of Enzymatic Analysis. Bergmeyer HU (ed.), Academic Press, Inc., New York. 2:673-684. Crossref |
||||
|
Azen SP, Qian D, Mack WJ, Sevanian A, Selzer RH, Liu CR, Liu CH, Hodis HN (1996). Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94(10):2369-2372. Crossref |
||||
|
Baynes JW (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40(4):405-412. Crossref |
||||
|
Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD (2003). A role for innate immunity in Type 1 diabetes. Diabetes Metab. Res. Rev. 19(2):89-100. Crossref |
||||
|
Bonnefont-Rousselot D (2002). Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 5(5):561-568. Crossref |
||||
|
Cao G, Alessio HM, Cutler RG (1993). Oxygen-radical absorbance ca-pacity assay for antioxidants. Free Radic. Biol. Med. 14(3):303-311. Crossref |
||||
|
Courderot-Masuyer C, Lahet JJ, Verges B, Brun JM, Rochette L (2000). Ascorbyl free radical release in diabetic patients. Cell. Mol. Biol. 46(8):1397-1401. Pubmed |
||||
|
Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006). Biomarkers of Oxidative Damage in Human Disease. Clin. Chem. 52(4):601-623. Crossref |
||||
|
Dominguez C, Ruiz E, Gussinye M, Carrascosa A (1998). Oxidative stress at onset and in early stages of type I diabetes in children and adolescents. Diabetes care 21(10):1736-1742. Crossref |
||||
|
El Samahy MH, Matter RM, Youssef OI, Shams El Din El Telbany MA, Kamal NA (2013). Relation between carotid intima media thickness and oxidative stress markers in Type 1 diabetic children and adolescents. J. Diabetes Metab. Disord. 12(1):50. Crossref |
||||
| Elstner EF, Youngman R, Obwad W (1983). Methods of Enzymatic Analysis vol. III. In: Bergmeyer HU, Grabl BM (eds.), Enzymes oxidoreductases 3rd ed. Weinheim: Verlag-Chemie, 3:293-302. | ||||
|
Ginty AT, Conklin SM (2012). Preliminary evidence that acute long-chain omega-3 supplementation reduces cardiovascular reactivity to mental stress: a randomized and placebo controlled trial. Biol. Psychol. 89(1):269-272. Crossref |
||||
| Goldberg DM, Spooner RJ (1992). Glutathione reductase. In: Bergmeyer HB (Ed.), Methods of Enzymatic Analysis. 3rd ed. 3:258-265. | ||||
|
Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G (1995). Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am. J. Med. 98(5):469-475. Crossref |
||||
|
Gumsulu S, Sarikcioglu SA, Sahin E, Yargicoglu P, Agar A (2002). Influence of different stress models on the antioxidant status and lipid peroxidation in rats erythrocytes. Free Radic. Res. 36(12):1277-1282. Crossref |
||||
| Halliwell B, Gutteridge JMC (1999). Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press, New York. pp. 617-783. | ||||
|
Halliwell B, Whiteman M (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142(2):231-255. Crossref |
||||
|
Heistad DD (2006). Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler. Thromb. Vasc. Biol. 26(4):689-695. Crossref |
||||
|
Hernández-Marco R, Codo-er-Franch P, Pons Morales S, Del Castillo Villaescusa C, Boix García L, Valls Bellés V (2009). Oxidant/antioxidant status and hyperfiltration in young patients with Type 1 diabetes mellitus. Pediatr. Nephrol. 24(1):121-127. Crossref |
||||
|
Jain SK (1989). Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 264(35):21340-21345. Pubmed |
||||
|
Jain SK, McVie R (1999). Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in Type 1 diabetic patients. Diabetes 48(9):1850-1855. Crossref |
||||
|
Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T, Kojima Y, Ohsaki Y, Ide H, Tsuji M, Kondo T, Kawakami Y (1985). Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin. Wochenschr. 63(16):765-768. Crossref |
||||
|
Kaplan LA, Cline D, Gartside P, Burnstein S, Sperling M, Stein EA (1982). Hemoglobin A1 in hemolysates from healthy and insulin-dependent diabetic children, as determined with a temperature-controlled mini column assay. Clin. Chem. 28(1):13-18. Pubmed |
||||
|
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shaltiel S, Stadtman ER (1990). Determination of carbonyl con-tent in oxidatively modified proteins. Methods Enzymol. 186:464-478. Crossref |
||||
|
Likidlilid A, Patchanans N, Poldee S, Peerapatdit T (2007). Glutathione and Glutathione Peroxidase in Type 1 Diabetic Patients. J. Med. Assoc. Thai. 90(9):1759-1767. Pubmed |
||||
|
Lin CC, Huang HH, Hu CW, Chen BH, Chong IW, Chao YY, Huang YL (2014). Trace elements, oxidative stress and glycemic control in young people with Type 1 diabetes mellitus. J. Trace. Elem. Med. Biol. 28(1):18-22. Crossref |
||||
| Linder B (2014). Overview of Diabetes in Children and Adolescents, From the National Diabetes Education Program (NDEP). Available at: http://ndep.nih.gov/media/Overview-of-Diabetes-Children-508_2014.pdf | ||||
|
Livingstone C, Davis J (2007). Targeting therapeutics against glutathione depletion in diabetes and its complications. Br. J. Diabetes Vasc. Dis. 7(6):258-265. Crossref |
||||
|
Lluís L, Taltavull N, Mu-oz-Cortés M, Sánchez-Martos V, Romeu M, Giralt M, Molinar-Toribio E, Torres JL, Pérez-Jiménez J, Pazos M, Méndez L, Gallardo JM, Medina I, Nogués MR (2013). Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats. Lipids Health Dis. 12(1):140. Crossref |
||||
|
Lyons TJ (1991). Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes. Diabet. Med. 8(5):411-419. Crossref |
||||
|
Maahs DM, Rewers M (2006). Mortality and renal disease in Type 1 diabetes mellitus progress made, more to be done. J. Clin. Endocrinol. Metab. 91(10):3757-3759. Crossref |
||||
|
Maritim AC, Sanders RA, Watkins JB 3rd (2003). Diabetes, oxidative stress and antioxidants: a review. J. Biochem. Mol. Toxicol. 17(1):24-38. Crossref |
||||
|
Merzouk S, Hichami A, Sari A, Madani S, Merzouk H, Yahia Berrouiguet A, Lenoir-Rousseaux JJ, Chabane-Sari N, and Khan NA (2004). Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. Gen. Physiol. Biophys. 23(4):387–399. Pubmed |
||||
|
Mishra N, Singh N (2013). Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control. N. Am. J. Med. Sci. 5(9):562-566. Crossref |
||||
|
Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95(2):351-358. Crossref |
||||
|
Ou P, Nourooz-Zadeh J, Tritschler HJ, Wolff S (1996). Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid. Free Radic. Res. 25(4):337-346. Crossref |
||||
|
Penno MA, Couper JJ, Craig ME, Colman PG, Rawlinson WD, Cotterill AM, Jones TW, Harrison LC (2013). Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of Type 1 diabetes. BMC Pediatr. 13(1):124. Crossref |
||||
|
Ramakrishna V, Jailkhani R (2007). Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn. Pathol. 2:22. Crossref |
||||
| Roe JH, Kuether CA (1943). The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivatives of dehydroascorbic acid. J. Biol. Chem. 147:399-407. | ||||
|
Sakurai T, Tsuchiya S (1988). Superoxide production from nonenzymatically glycated protein. FEBS. Lett. 236(2):406-410. Crossref |
||||
|
Sato Y, Hotta N, Sakamoto N (1979). Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21(1):104-107. Crossref |
||||
| Sies H (1991). Oxidative stress: Oxidants and antioxidants. New York, Academic Press. | ||||
|
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197 Crossref |
||||
|
Thomas HE, Kay TWH (2000). Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab. Res. Rev. 16(4):251-261. Crossref |
||||
|
Vantyghem MC, Balduyck M, Zerimech F, Martin A, Douillard C, Bans S, Degand PM, Lefebvre J (2000). Oxidative markers in diabetic ketoacidosis. J. Endocrinol. Investig. 23(11):732-736. Crossref |
||||
|
Varvarovská J, Racek J, Stozický F, Soucek J, Trefil L, Pomahacová R (2003). Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. J. Diabetes Complications 17(1):7-10. Crossref |
||||
|
Velazquez E, Winocour PH, Kesteven P, Alberts KG, Laker MF (1991). Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet. Med. 8(8):752-758. Crossref |
||||
|
Vlassara H (1994). Recent progress on the biologic and clinical significance of advanced glycosylation end products. J. Lab. Clin. Med. 124(1):19-30. Pubmed |
||||
|
Wierusz-Wysocka B, Wysocki H, Byks H, Zozulinska D, Wykretowicz A, Kamzmierczak M (1995). Metabolic control quality and free radical activity in diabetic patients. Diabetes Res. Clin. Pract. 27(3):193-197. Crossref |
||||
|
Wolff SP (1993). Diabetes mellitus and free radicals. Br. Med. Bull. 49(3):642-652. Pubmed |
||||
|
Yu BP (1994). Cellular defences against damage from reactive oxygen species. Physiol. Rev. 74(1):139-162. Pubmed |
||||
|
Zivić S, Vlaski J, Kocić G, Pesić M, Cirić V, Durić Z (2008). The importance of oxidative stress in pathogenesis of Type 1 diabetes--determination of catalase activity in lymphocytes of diabetic patients. Med. Pregl. 61(9):458-463. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
